Trademark: TARGETED MOLECULAR IMMUNOTHERAPY
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
TARGETED MOLECULAR IMMUNOTHERAPY
Click here to search for trademarks similar to TARGETED MOLECULAR IMMUNOTHERAPY
Proof of use for TARGETED MOLECULAR IMMUNOTHERAPY
We do not have any records of a proof of use for TARGETED MOLECULAR IMMUNOTHERAPY at this moment.
Click here to add a proof of use for TARGETED MOLECULAR IMMUNOTHERAPY
Possible trademark infringements of TARGETED MOLECULAR IMMUNOTHERAPY
Basic Information about TARGETED MOLECULAR IMMUNOTHERAPY
- Serial Number
- 85363912
- Filing Date
- 06 Jul 2011
- Registration Number
- 4185255
- Registration Date
- 07 Aug 2012
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of TARGETED MOLECULAR IMMUNOTHERAPY on the blockchain with WikiTrademarks.io.
- First use of TARGETED MOLECULAR IMMUNOTHERAPY anywhere
- TARGETED MOLECULAR IMMUNOTHERAPY was first used on 09 Feb 2005 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 2
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns TARGETED MOLECULAR IMMUNOTHERAPY?
1. Globeimmune, Inc. Louisville CO
2. Globeimmune, Inc. Louisville CO
3. Globeimmune, Inc. Louisville CO
Correspondent
- SABRINA C. STAVISH
- SHERIDAN ROSS P.C.
- 1560 BROADWAY STE 1200
- DENVER, CO 80202-5145
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io